| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Net income | 1.5 | 0.8 |
| EPS (diluted, $ a share) | $0.07 | $0.05 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +78.2% |
|---|
10-Q filed with the SEC, NYSE: REMC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Remora Capital Corp: key numbers
- Share price
- $23.09Close, Nov 16
- Market cap
- $505M
- Shares outstanding
- 21.87MLatest SEC cover page
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Remora Capital Corp
All →Remora Capital Shareholder Meeting
Remora Capital Corporation held its Annual Meeting of Stockholders on November 5, 2026. Stockholders elected Daniel Mafrice as a director to serve a three-year term, with 11,042,512 votes cast in favor.
Remora Capital Capital Raise of $1.97M
Remora Capital Corporation issued 201,641.027 shares of common stock at $9.75 per share to investors. The private placement resulted in aggregate proceeds of approximately $1.97 million and was conducted as an unregistered sale exempt from SEC registration.
- Value
- $1.97M
Remora Capital Capital Raise of $1.04M
Remora Capital Corporation issued 106,974.359 shares of common stock to investors at a price of $9.75 per share. The private placement resulted in aggregate proceeds of approximately $1.043 million and was conducted under a Section 4(a)(2) exemption.
- Value
- $1.04M
Remora Capital Business Update
Remora Capital Corporation entered into an amended and restated investment sub-advisory agreement with Crescent Capital Group LP and Remora Capital Management, LLC. The amendment adds technical provisions to comply with Rule 17a-10 of the Investment Company Act of 1940, specifically limiting Crescent's responsibilities to sub-advised assets and restricting consultations with other sub-advisers. The management fee and the original two-year term beginning September 5, 2025, remain unchanged.
- Counterparty
- Crescent Capital Group LP
- Term
- through Sept 2027